Transcription of Appendix A: Disease-Specific Chapters
{{id}} {{{paragraph}}}
Infectious Diseases Protocol Appendix A: Disease-Specific Chapters chapter : Meningococcal disease , invasive Revised January 2014 2 Meningococcal disease , invasive Communicable Virulent Health Protection and Promotion Act: Ontario Regulation 558/91 Specification of Communicable Diseases Health Protection and Promotion Act: Ontario Regulation 559/91 Specification of Reportable Diseases Aetiologic Agent Meningococcal disease is caused by Neisseria meningitidis, a Gram-negative, Meningococcal serogroups are classified according to the immunological reactivity of the capsular Serogroup A, B, C, Y and W-135 are most commonly associated with invasive meningococcal disease (IMD).3 Case Definition Surveillance Case Definition See Appendix B. Outbreak Case Definition Public health units should notify Public Health Ontario (PHO), as specified by the Ministry of Health and Long-Term Care (the Ministry), when a case is identified.
All identified contacts should be alerted to signs and symptoms of IMD and advised to seek medical attention immediately should they develop febrile illness or any other clinical manifestations of IMD.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Investigation of Contacts of Persons, Contacts, Bearing investigation, AGENCY CONTACTS FOR FINANCIAL DISCLOSURE, Investigation, MICHIGAN, Investigation, Revenue and Enforcement Administration, Investigation of Pro-Poor Local Economic Development, Local Economic Development, Investigation of Pro-Poor, Connecticut